There is a shortage of drugs against cancer drug. This can not be true, can it?
Oh, but it is. From this week, 28 drugs against cancer taken by more than 550,000 patients across the country are in short supply. You read: 28.
In a survey conducted by National Analysts Worldwide in January 2012, 46 percent of oncologists reported that there were times in the past year, when patients were unable to receive timely treatment due to shortages of goods and 31 percent said it happens every month.
each month? This means that there are thousands of cancer patients who do not receive their medications every month. How can this happen
You guessed it: It comes down to money. Companies that manufacture these drugs have a lower profit margin because many of these cancer drugs have been made in a generic form. Fewer suppliers are interested in making these expensive drugs, even if they are the best quality product and are not 100 percent replaceable by their generic counterparts.
There are indeed some chemotherapeutic agents for mesothelioma are on the shortage list, such as:
-
carboplatin : a modified version of cisplatin;
-
Cisplatin injection most commonly used to treat ovarian, lung, head and neck cancers and has recently shown some success in treating mesothelioma: this platinum-based chemotherapy. medicament is used to treat a variety of cancers; its most basic use is to promote cell death
-
doxorubicin injection :. one of the chemotherapeutic agents most commonly used to treat mesothelioma. Doxorubicin has shown to prolong the life of patients with mesothelioma.
To fight against the shortage, a bill was presented to the Capitol would require the Food and Drug Administration (FDA) and drug manufacturers to list shortages and allow the Drug Enforcement Agency (DEA) to transfer quotas, among others. The "shortage of drugs Prevention Act" would require the FDA to take several steps to monitor the problem more aggressively and improve communication within the industry and the medical community.
Apart the development of an essential medicines list, which would identify drugs that are vulnerable to shortages, the legislation should also require the FDA to notify distributors of imminent shortage. Click here to read the text full of the drug shortage prevention Act.
Are you someone that you know or take one of these drugs against cancer?
Share with us on Facebook, Twitter or in the comments below. to recommend this item to your friends, give us a +1 on Google+.
